Automation, Collaboration and the Future of Advanced Therapies

In this episode of Denatured, you’ll hear from Jason Jones, head of global business development at Cellular Origins and Alexander Seyf, founder & CEO of Autolomous. They discuss how the push to scale cell and gene therapy manufacturing is accelerating interest in automation, digitization, robotics and deeper collaboration across the ecosystem.

> Listen on Spotify
> Listen on Apple Podcasts
> Listen on Amazon Music

In this Denatured episode, Jennifer C. Smith-Parker speaks to Jason Jones, head of global business development at Cellular Origins and Alexander Seyf, founder & CEO of Autolomous. We discuss how rising demands on cell and gene therapy manufacturing are prompting developers and manufacturers to embrace automation, digitization, robotics and stronger ecosystem-wide collaboration.

Host

⁠Jennifer C. Smith-Parker⁠, Director of Insights, BioSpace

Guests

Jason Jones, Head of Global Business Development, Cellular Origins

Alexander Seyf, Founder & CEO, Autolomous

Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.

Jennifer C. Smith-Parker is Director of Insights at BioSpace. She has been been immersed for 20 years in healthcare, first as a journalist and editor before pivoting to corporate, brand, and product communications. A skilled storyteller, she is adept at creating diverse content across platforms and crafting narratives that drive engagement, strengthen reputation, and deliver measurable growth. You can reach her at Jennifer.Smith-Parker@BioSpace.com.
The BioSpace Insights teams performs research and analysis on industry trends for BioSpace and clients, producing industry reports, podcasts, events and articles.
MORE ON THIS TOPIC